(Q40918717)

24 September 2017

1 reference

title

Altered serotonergic activity in women with dysphoric premenstrual syndromes (English)

1 reference

24 September 2017

U Halbreich

1

1 reference

PubMed ID

8514462

24 September 2017

H Tworek

series ordinal

2

1 reference

24 September 2017

1 January 1993

1 reference

International Journal of Psychiatry in Medicine

24 September 2017

1 reference

24 September 2017

23

1 reference

24 September 2017

1-27

1 reference

24 September 2017

1

1 reference

The serotonin hypothesis of (auto)aggression. Critical appraisal of the evidence

24 September 2017

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Role of serotonin in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Abnormalities of indoleamines in affective disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Role of Serotonergic Input in the Regulation of the β-Adrenergic Receptor-Coupled Adenylate Cyclase System

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

A strong influence of serotonin axons on beta-adrenergic receptors in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Hormonal probes of central serotonergic activity: do they really exist?

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Therapeutic indications for serotonin-potentiating compounds: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Serotonin function in panic disorders. The effect of intravenous tryptophan in healthy subjects and patients with panic disorder before and during alprazolam treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Recent developments in 5HT-related pharmacology of animal models of anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Cerebrospinal fluid amine metabolites. Relationships with behavioral measurements in depressed, manic, and healthy control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Serotonin function in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Serotonin and anxiety revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Pharmacological and clinical effects of buspirone

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Aggression in humans correlates with cerebrospinal fluid amine metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Aggression, suicide, and serotonin: relationships to CSF amine metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Carbohydrate craving, conduct disorder, and low 5HIAA.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

21 January 2018

Serotonin and appetite

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Low doses of the putative serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicit feeding in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

5-Hydroxytryptamine and antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Sex differences in serotonin 1 receptor binding in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Gonadal Steroid Action on the Brain: Neurochemistry and Neuropharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

The menstrual cycle and platelet 5-HT uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Platelet research in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Oral contraceptives, pyridoxine, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Sex specific differences in chlorimipramine inhibition of serotonin uptake in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Human platelet monoamine oxidase changes during the menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Platelet monoamine oxidase activity and plasma 3,4-dihydroxyphenylethylene glycol levels during the menstrual cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Serotonin receptor modulation by estrogen in discrete brain nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Effects of steroid hormones on the serotonergic system

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Influence of progesterone on serotonin metabolism: a possible causal factor for mood changes

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

The effect of oestradiol dipropionate and progesterone on monoamioe uptake in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Induction of migrainelike headaches by the serotonin agonist m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Neuroendocrine evidence for serotonin receptor hypersensitivity in panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Serotonergic responsivity in obsessive-compulsive disorder. Effects of chronic clomipramine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

5-HT-1a and 5-HT-1b selectivity of two phenylpiperazine derivatives: evidence for 5-HT-1b heterogeneity.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Effects of m-chlorophenylpiperazine on receptor binding and brain metabolism of monoamines in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

[3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Endocrinological responses to 5-HT.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Neuroendocrine [corrected] regulation of prolactin release

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Distribution of serotonin receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Buspirone in the treatment of alcoholic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

The role of the 5-HT2 receptor in the regulation of sexual performance of male rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Serotonin agents in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Functional correlates of serotonin 5-HT1 recognition sites

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Serotonin receptor sensitivity in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Fluvoxamine in the treatment of menstrually related mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

The actions of diazepam and serotonergic anxiolytics vary according to the gender and the estrous cycle phase.

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2190%2FJ2W0-RTGD-NYKK-FF77

10.2190/J2W0-RTGD-NYKK-FF77

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8514462